# The LINFU® U.S. Registry in Patients With Clinical Signs and/or Symptoms of Disease

> **NCT06276738** · — · NOT_YET_RECRUITING · sponsor: **Adenocyte, LLC** · enrollment: 1000 (estimated)

## Conditions studied

- Pancreatic Cancer
- Jaundice
- Abdominal Neoplasm

## Interventions

- **DIAGNOSTIC_TEST:** LINFU® (Low Intensity Non-Focused Ultrasound excitation of the pancreas)

## Key facts

- **NCT ID:** NCT06276738
- **Lead sponsor:** Adenocyte, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-06-30
- **Primary completion:** 2034-03-01
- **Final completion:** 2034-05-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06276738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06276738, "The LINFU® U.S. Registry in Patients With Clinical Signs and/or Symptoms of Disease". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT06276738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*